Navigation Links
AccessClosure, Inc. Marches to the Millionth Mynx!
Date:9/27/2011

MOUNTAIN VIEW, Calif., Sept. 27, 2011 /PRNewswire/ -- AccessClosure, Inc., a leading manufacturer of extravascular closure devices, announced today the shipment of its one millionth Mynx unit. The Mynx Vascular Closure Device received its FDA approval in May 2007, following with its full commercial launch in September 2007. Physician feedback attributes the achievement of this monumental milestone to the fact that the Mynx sealant is extravascular, bio-inert and non-thrombogenic, while leaving nothing behind intra-arterially.

(Logo: http://photos.prnewswire.com/prnh/20110111/SF27857LOGO)

"It is gratifying that one million patients will have benefited from the Mynx device just four and a half years after introduction to the marketplace. Excellent clinical efficacy and safety have been demonstrated with the Mynx device, and both physicians and their patients greatly appreciate the device's comfort profile," said Gregory D. Casciaro, President and CEO of AccessClosure, Inc.

In addition, increased patient comfort continues to resonate with both physicians and nurses as one of their top selection criteria in choosing the Mynx as their preferred extravascular closure device. Results from a recent prospective, randomized study indicate a significant reduction in pain with the Mynx Vascular Closure Device when compared to competitive devices. The study found that 88% of patients find closure to be the most painful part of the procedure when a competitive device was used compared to 34% of patients when the Mynx device was used.  

"Today is a monumental occasion for AccessClosure, Inc.," said Fred Khosravi, Chairman of the Board and co-founder of AccessClosure. "Vascular closure has been one of the most competitive segments in the medical device marketplace, controlled by a handful of competitors.  Not since the Mynx received its approval four years ago has any other company been so well accepted and utilized in this space. The success of Mynx is just the beginning. AccessClosure, Inc. will continue to meet the needs of its customer base for years to come with its robust product pipeline."

Also contributing to the overall success of Mynx is the continued expansion of its distribution network through international markets; demonstrated most recently with the announcement of the Biosensors International distribution agreement throughout the United Kingdom, Switzerland and France. The Mynx Device is now available through a wide global network of distributors, complementing its direct sales presence in the United States.

About AccessClosure, Inc.

Founded in 2002, AccessClosure, Inc. is a privately held medical device company pioneering innovative access site management products designed to provide a reliable, patient-friendly vascular closure experience. For more information, please visit our website at http://www.accessclosure.com/


'/>"/>
SOURCE AccessClosure, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Systech and Marchesini Showcase Complete Serialization Line at Pack Expo 2010
2. Solta Medical Ships One Millionth Tip for Thermage and Fraxel Devices
3. The SCOOTER Store Marks Half-Millionth Life Changed
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/11/2016)... Feb. 11, 2016  Delcath Systems, Inc. (NASDAQ: ... device company focused on oncology with an emphasis ... cancers, announces the engagement of Lars E. ... Medical Consultant. Dr. Birgerson will provide strategic medical ... operations team to help ensure timely facilitation of ...
(Date:2/11/2016)... 11, 2016 SI-BONE, Inc., a medical ... iFuse Implant System, a minimally invasive surgical (MIS) ... the sacroiliac (SI) joint, announced the publication of ... MIS SI joint fusion for patients suffering from ... or SI joint disruption.  In the first article, ...
(Date:2/11/2016)... CARLSBAD, Calif. , Feb.11, 2016  Ionis Pharmaceuticals, Inc. ... a live webcast on Thursday, February 25 at 11:30 a.m. ... on pipeline and business progress. www.ionispharma.com . ... at the same address. --> www.ionispharma.com . A ... the same address. --> Interested parties may listen ...
Breaking Medicine Technology:
(Date:2/11/2016)... NEW ORLEANS (PRWEB) , ... February 11, 2016 , ... ... : Achieving Satisfaction through a Well Managed Mind” (published by Balboa Press) teaches readers ... unique way of being through profound love, author Janice McDermott, M.Ed., LCSW, offers an ...
(Date:2/11/2016)... ... February 11, 2016 , ... Student-doctors from Western University of ... Program Tuesday, February 9, taking one of the final steps in their medical ... positions across the country. Of the 103 student-doctors who comprise the College of ...
(Date:2/11/2016)... ... 2016 , ... Florida Hospital presents Heart Health Awareness night on Sunday February ... the Amalie Arena. The puck drops at 6:00pm, but fans will have the opportunity ... to the game. The MEGA Heart will be located on Ford Thunder Alley and ...
(Date:2/11/2016)... Alexandria, Va. (PRWEB) , ... February 11, 2016 , ... ... for the DoD Military Health System but would shift more of the cost burden ... described the TRICARE-reform plan laid out in the defense budget as including limited quantifiable ...
(Date:2/11/2016)... ... February 11, 2016 , ... Pediatric cardiovascular surgeons, cardiologists ... by making data on heart procedures public and easily understandable for families and ... Reporting of Pediatric and Congenital Heart Disease Outcomes will bring hundreds of pediatric ...
Breaking Medicine News(10 mins):